What’s ahead for Eli Lilly and Novo as RFK Jr. takes over HHS
Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the ...
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Minnesota Daily5d
Insulin costs capped at $35 per month in Minnesota
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...
Journal.ie on MSN5d
'King Kong' of weight-loss drugs, Mounjaro, will be available in Ireland from next week
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...